Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes

DT Cody II, Y Huang, CJ Darby, GK Johnson… - Oral oncology, 1999 - Elsevier
The p16 INK4A tumor suppressor gene participates in establishing and maintaining the
malignant phenotype of a variety of cancer cell lines and primary tumors. Recently it has …

p16INK4a Promoter Is Hypermethylated at a High Frequency in Esophageal Adenocarcinomas

DJ Wong, MT Barrett, R Stöger, MJ Emond, BJ Reid - Cancer research, 1997 - AACR
Loss of heterozygosity (LOH) of 9p21, which contains the p16INK4a tumor suppressor gene
locus, is one of the most frequent genetic abnormalities in human neoplasia, including …

Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma

K Fukai, O Yokosuka, F Imazeki, M Tada… - Liver …, 2005 - Wiley Online Library
Background: The INK4 locus consisting of three genes involved in the regulation of cell
cycle, p16INK4a, p15INK4b, and p14ARF is often disrupted in human neoplasms. Methods …

[HTML][HTML] Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma

A Csepregi, MPA Ebert, C Röcken, R Schneider-Stock… - BMC cancer, 2010 - Springer
Background The product of CDKN2A, p16 is an essential regulator of the cell cycle
controlling the entry into the S-phase. Herein, we evaluated CDKN2A promoter methylation …

Germ-line mutations of thep16INK4 (MTS1) gene occur in a subset of patients with hepatocellular carcinoma

P Chaubert, R Gayer, A Zimmermann, C Fontolliet… - Hepatology, 1997 - journals.lww.com
The molecular mechanisms of hepatocarcinogenesis are poorly understood. Only very
recently has there been a suggestion of familial hepatocellular carcinoma (HCC). We have …

Hypermethylation of the p16INK4a Promoter in Colectomy Specimens of Patients with Long-standing and Extensive Ulcerative Colitis

CJ Hsieh, B Klump, K Holzmann, F Borchard, M Gregor… - Cancer research, 1998 - AACR
Functional inactivation of the p16INK4a gene has been reported to be involved in the
development of a variety of human malignancies. Recent evidence shows that …

CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables

QN Vo, J Geradts, DA Boudreau, JC Bravo… - Human pathology, 2002 - Elsevier
The CDKN2A gene encodes a cyclin-dependent kinase inhibitor, p16, which promotes cell
cycle arrest. Methylation of the promoter region of the gene transcriptionally inactivates the …

[HTML][HTML] Promoter and histone methylation and p16INK4A gene expression in colon cancer

EE Yoruker, U Mert, D Bugra… - Experimental and …, 2012 - spandidos-publications.com
The inactivation of the cyclin-dependent kinase inhibitor p16INK4A gene by
hypermethylation is observed in numerous types of cancer. New findings indicate that DNA …

[HTML][HTML] H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells

JY Yao, L Zhang, X Zhang, ZY He, Y Ma, LJ Hui… - Journal of Biological …, 2010 - ASBMB
Stable epigenetic silencing of p16 INK4a is a common event in hepatocellular carcinoma
(HCC) cells, which is associated with abnormal cell proliferation and liberation from cell …

Evidence that P12, a specific variant of P16INK4A, plays a suppressive role in human pancreatic carcinogenesis

MJ Poi, TJ Knobloch, C Yuan, MD Tsai… - Biochemical and …, 2013 - Elsevier
The INK4a-ARF locus plays a central role in the development of pancreatic tumors as
evidenced by the fact that up to 98% of pancreatic tumor specimens harbored genetic …